openPR Logo
Press release

Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

05-08-2025 02:10 PM CET | Health & Medicine

Press release from: The Business Research Company

Pharmaceutical Contract Development And Manufacturing Organization (CMO)

Pharmaceutical Contract Development And Manufacturing Organization (CMO)

The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size and Projected Growth Rate?
There has been a significant increase in the market size of the pharmaceutical contract development and manufacturing organization (CMO) in the past few years. Expected to increase from $174.33 billion in 2024 to about $186.62 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. This considerable expansion during the historical period is due to robust economic growth in emerging markets, an escalation in healthcare spending, a surge in pharmaceutical research and development (R&D) expenditure and a growing tendency towards outsourcing.

The market size of the pharmaceutical contract development and manufacturing organization (CMO) is slated for robust expansion in the upcoming years. The market is projected to reach a size of $260.83 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This surge during the forecast period is due to factors like surging government backing, expanded healthcare access, heightened investment, and advancements in biopharmaceutical development. Emerging trends over the forecast period include a heightened emphasis on sustainability, integrated application of artificial intelligence and digitization, the advent of resilient and innovative products, as well as increased investment and strategic alliances among market participants.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2825

What Are the Major Segments in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented -

1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies

Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp

What Are The Driving Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Evolution?
The surge in the pharmaceutical contract development and manufacturing market can be attributed to the growing global demand for medicines. Given the widespread occurrence of diseases and the desire for extended longevity, there has been a heightened requirement for medications. This compels pharmaceutical firms to boost production of their existing pharmaceuticals and increase their research and development investment to stimulate the creation of new medications. To decrease operational expenses, these companies have begun to seek partnerships with contract manufacturing organizations (CMOs), thus stimulating the pharmaceutical contract development and manufacturing market. Alkermes PLC., a biopharmaceutical company, suggests that pharmaceutical contract manufacturing is likely to become a strategic choice for a wide range of companies, from large scale to niche specialty pharmaceutical entities, primarily driven by the pharmaceutical industry's quest for cost reduction.

Which Firms Dominate The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segments?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals

What Trends Are Driving Growth in The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Firms in the pharmaceutical contract development and manufacturing market are channeling their investments into acquisitions and partnerships with other players in the same market. This trend appears to be driven by the desire to broaden their worldwide market presence, fulfill client requirements, enhance their production abilities while keeping costs in check, and gain entry to cutting-edge technology and new services. This habit of engaging in mergers and acquisitions leads to a consolidation among contract service providers. For example, Pharma Nobis, a firm based in the U.S. that provides contract manufacturing and private label services, bought out Fagron's U.S. contract manufacturing operations in July 2022 for an undisclosed sum. This move is projected to enable Pharma Nobis to supply contract manufacturing and private label services to retailers and consumer healthcare firms in America. Fagron will retain a 20% ownership of the company.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-contract-developments-and-manufacturing-organization-cmo-global-market-report

Which Is The Largest Region In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
2. What is the CAGR expected in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
3. What Are the Key Innovations Transforming the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry?
4. Which Region Is Leading the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here

News-ID: 4005879 • Views:

More Releases from The Business Research Company

Healthcare Business Intelligence Market Insights 2025-2034: Growth Forecast and Strategic Priorities
Healthcare Business Intelligence Market Insights 2025-2034: Growth Forecast and …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Healthcare Business Intelligence Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of healthcare business intelligence has experienced a swift expansion in the past few years. The market is projected to escalate from a worth of $10.38 billion in 2024 to $11.97 billion in 2025, recording a compound
Strategic Forecast for the Hand Sanitizer Dispenser Industry: Market Outlook 2025-2034
Strategic Forecast for the Hand Sanitizer Dispenser Industry: Market Outlook 202 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Hand Sanitizer Dispenser Market Size Growth Forecast: What to Expect by 2025? The scale of the hand sanitizer dispenser market has swiftly expanded in the past few years. The industry is forecasted to expand from $0.14 billion in 2024 to $0.17 billion in 2025, boasting a compound annual growth rate (CAGR) of 18.4%. Various
Green Cement Market Growth Fueled By Climate Awareness And Carbon Emissions Reduction Efforts Driving Market Acceleration in the Green Cement Industry, 2025
Green Cement Market Growth Fueled By Climate Awareness And Carbon Emissions Redu …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Green Cement Market Size By 2025? In recent times, the market size of green cement has remarkably increased. The market is projected to escalate from $32.57 billion in 2024 to $35.51 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. The historic growth can be credited to
Glass Façade: A Leading Driver Behind Increasing Construction Investments Driving Growth In The Glass Façade Market Market Expansion in 2025
Glass Façade: A Leading Driver Behind Increasing Construction Investments Driv …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Will the Glass Façade Industry Market Size Be by 2025? The value of the glass façade market has been on a consistent upward trend in past years. This market is projected to expand from a value of $172.19 billion in 2024 to $178.98 billion in 2025, reflecting a compound annual growth rate (CAGR)

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications